Provided by Tiger Trade Technology Pte. Ltd.

Indaptus Therapeutics, Inc.

1.13
-0.0150-1.31%
Post-market: 1.130.00000.00%16:04 EDT
Volume:66.63K
Turnover:75.40K
Market Cap:150.29M
PE:-2.40
High:1.16
Open:1.10
Low:1.10
Close:1.15
52wk High:8.57
52wk Low:0.9200
Shares:133.00M
Float Shares:23.24M
Volume Ratio:0.25
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4709
EPS(LYR):-21.5800
ROE:-318.04%
ROA:-98.08%
PB:13.22
PE(LYR):-0.05

Loading ...

Indaptus Therapeutics Enters Amended ATM Equity Distribution Agreement for up to $100 Million Common Stock Offering

Reuters
·
Yesterday

Indaptus Therapeutics Inc: Files for Offering of up to $100 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 31

Indaptus Therapeutics - Proposed Resale of up to 58,895,000 Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 18

Indaptus Q2 Net Loss Narrows as Costs Fall

Reuters
·
Aug 13

Indaptus Therapeutics Q2 EPS USD -0.02

THOMSON REUTERS
·
Aug 13

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 13

Insider Traders Lose US$34k As Indaptus Therapeutics Drops

Simply Wall St.
·
Jul 08

Indaptus Therapeutics Inc - Files for Resale by the Selling Stockholders of up to 18.86 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 27

Indaptus Therapeutics - to Issue 20 Mln Shares at $0.6 Per Share - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics - Private Placement Gross Proceeds About $12 Mln Before Expenses - SEC Filing

THOMSON REUTERS
·
Jun 25

Indaptus Therapeutics Sells 20,000,000 Shares at $0.6 in $12 Million Private Placement

Reuters
·
Jun 25

Top Premarket Decliners

MT Newswires Live
·
Jun 05

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM

Reuters
·
Jun 05

Indaptus Therapeutics Q1 net loss narrows as expenses fall

Reuters
·
May 15

Indaptus net loss narrows to $2.5 million in Q1 FY26; R&D expenses drop 82% to $491,134

Reuters
·
May 15

Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 15

Indaptus Therapeutics Q1 EPS USD -0.23

THOMSON REUTERS
·
May 15

Indaptus Therapeutics Inc expected to post a loss of $1.87 a share - Earnings Preview

Reuters
·
May 08

Indaptus amends 8-K to reflect director Johnny Fox Arrowsmith legal name change

Reuters
·
Apr 25

Indaptus Therapeutics director Qinglai Lu files initial beneficial ownership statement

Reuters
·
Apr 21